Suppr超能文献

地塞米松和酮咯酸对妇科腹腔镜手术患者术后恶心呕吐的影响及危险因素评估。

The influence of dexamethasone and ketolgan on postoperative nausea and vomiting and estimation of risk factors in women undergoing gynecologic laparoscopic surgeries.

机构信息

Department of Gynecology and Obstetrics, Kaunas University of Medicine, 50009 Kaunas, Lithuania.

出版信息

Medicina (Kaunas). 2010;46(4):261-7.

Abstract

UNLABELLED

The aim of this study was to determine the effect of dexamethasone and ketolgan on postoperative nausea and vomiting and to evaluate risk factors for postoperative nausea and vomiting.

MATERIAL AND METHODS

A prospective, double-blind, randomized clinical study was carried out. One hundred fifty-three ASA I-II women undergoing laparoscopic gynecologic operations were randomized into three groups: dexamethasone group (n=51), ketolgan group (n=51), and control group (n=51). Patients in the dexamethasone group were given 4 mg of dexamethasone intravenously before the induction of general anesthesia, the ketolgan group received 30-mg ketolgan intravenously, and control group did not receive any medication. The incidence and severity of postoperative nausea and vomiting were registered 24 hours after the surgery.

RESULTS

The incidence of postoperative nausea and vomiting in the dexamethasone group was 13.8%; in the ketolgan group, 37.3%, and in the control group, 58.9% (P=0.026). Patients with a history of migraine suffered from postoperative nausea and vomiting in 70.3% of cases and migraine-free patients in 25.8% of cases (P=0.015). Opioids for postoperative analgesia increased the incidence of postoperative nausea and vomiting as compared with nonsteroidal anti-inflammatory drugs (P=0.00002).

CONCLUSIONS

Preoperative medication with dexamethasone significantly reduces the incidence of postoperative nausea and vomiting. Avoidance of opioids for postoperative analgesia reduces the incidence of postoperative nausea and vomiting. Migraine and motion sickness are independent risk factors for postoperative nausea and vomiting.

摘要

未加标签

本研究旨在确定地塞米松和酮咯酸对术后恶心和呕吐的影响,并评估术后恶心和呕吐的危险因素。

材料和方法

进行了一项前瞻性、双盲、随机临床试验。将 153 名 ASA I-II 级接受腹腔镜妇科手术的女性随机分为三组:地塞米松组(n=51)、酮咯酸组(n=51)和对照组(n=51)。地塞米松组患者在全身麻醉诱导前静脉注射 4 毫克地塞米松,酮咯酸组患者静脉注射 30 毫克酮咯酸,对照组患者未接受任何药物治疗。术后 24 小时登记术后恶心和呕吐的发生率和严重程度。

结果

地塞米松组术后恶心和呕吐的发生率为 13.8%;酮咯酸组为 37.3%,对照组为 58.9%(P=0.026)。有偏头痛病史的患者中 70.3%发生术后恶心和呕吐,无偏头痛病史的患者中 25.8%发生术后恶心和呕吐(P=0.015)。与非甾体抗炎药相比,术后使用阿片类药物进行镇痛会增加术后恶心和呕吐的发生率(P=0.00002)。

结论

术前使用地塞米松可显著降低术后恶心和呕吐的发生率。避免术后使用阿片类药物进行镇痛可降低术后恶心和呕吐的发生率。偏头痛和晕车是术后恶心和呕吐的独立危险因素。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验